Masao Matsuoka Selected Research

Masao Matsuoka Research Topics

Disease

34	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 11/2022 - 01/2002
26	Infections 01/2021 - 04/2002
18	Neoplasms (Cancer) 06/2022 - 06/2003
18	T-Cell Leukemia (Leukemia, T Cell) 03/2021 - 08/2002
10	Lymphoma (Lymphomas) 06/2022 - 06/2003
8	Carcinogenesis 12/2018 - 08/2005
6	Multiple Myeloma 01/2022 - 01/2019
4	Inflammation (Inflammations) 01/2020 - 08/2015
4	HIV Infections (HIV Infection) 12/2019 - 04/2002
4	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 01/2018 - 08/2002
3	Spinal Cord Diseases 01/2019 - 08/2002
3	T-Cell Lymphoma (Lymphoma, T Cell) 10/2015 - 08/2002
2	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2022 - 07/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 07/2017 - 07/2017
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2013 - 10/2008
2	Virus Diseases (Viral Diseases) 11/2012 - 09/2012
1	Amyloidosis 01/2022
1	Diarrhea 11/2021
1	Immunoglobulin Light-chain Amyloidosis 11/2021
1	Myeloid Sarcoma (Chloroma) 08/2021
1	Hematologic Neoplasms (Hematological Malignancy) 07/2021
1	Hypoxia (Hypoxemia) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018
1	Cytopenia 07/2018

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2007
6	Messenger RNA (mRNA)IBA 01/2021 - 01/2006
6	Pharmaceutical PreparationsIBA 08/2016 - 09/2006
5	CytokinesIBA 01/2020 - 08/2002
5	LigandsIBA 01/2019 - 09/2006
4	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2008
4	6H- 6- imino- (2,3,4,5- tetrahydropyrimido)(1,2- c)- (1,3)benzothiazineIBA 04/2015 - 09/2012
4	DNA (Deoxyribonucleic Acid)IBA 12/2009 - 04/2004
3	mogamulizumabIBA 03/2022 - 01/2018
3	ParaffinIBA 01/2022 - 11/2016
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2006
3	Bortezomib (Velcade)FDA Link 11/2021 - 07/2004
3	Macrophage Colony-Stimulating FactorIBA 01/2019 - 01/2002
3	IminesIBA 04/2015 - 11/2012
3	NucleosidesIBA 12/2009 - 01/2007
3	Reverse Transcriptase InhibitorsIBA 12/2009 - 11/2006
2	Formaldehyde (Formol)FDA Link 01/2022 - 01/2019
2	fludarabineIBA 07/2021 - 08/2012
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2010
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 08/2002
2	Cell Adhesion Molecule-1IBA 12/2018 - 07/2017
2	InterleukinsIBA 01/2018 - 08/2002
2	Immune Checkpoint ProteinsIBA 07/2017 - 11/2016
2	MucinsIBA 07/2017 - 11/2016
2	Immunoglobulins (Immunoglobulin)IBA 07/2017 - 11/2016
2	Anti-HIV Agents (AIDS Drugs)IBA 10/2015 - 04/2002
2	InterferonsIBA 10/2015 - 08/2015
2	Anti-Retroviral Agents (Antiretroviral Agents)IBA 04/2015 - 11/2012
2	pyrimidineIBA 04/2015 - 04/2015
2	Oncogene Proteins (Oncogene Protein)IBA 04/2015 - 04/2007
2	Tenofovir (Viread)FDA Link 04/2013 - 11/2006
2	Zidovudine (Retrovir)FDA LinkGeneric 04/2013 - 11/2006
2	Peptides (Polypeptides)IBA 12/2010 - 01/2008
2	EnzymesIBA 12/2009 - 01/2008
2	AntigensIBA 08/2009 - 04/2002
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2009 - 04/2004
2	Viral ProteinsIBA 08/2005 - 08/2003
1	LipidsIBA 06/2022
1	PD 128042IBA 06/2022
1	CholesterolIBA 06/2022
1	dimorpholinethiuram disulfideIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Lenalidomide (CC 5013)FDA Link 01/2022
1	daratumumabIBA 01/2022
1	Busulfan (Busulfex)FDA Link 07/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2021
1	Methotrexate (Mexate)FDA LinkGeneric 07/2021
1	ElementsIBA 03/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	Histidine (L-Histidine)FDA Link 01/2021
1	bis(5'-adenosyl)triphosphataseIBA 01/2021
1	Positive Transcriptional Elongation Factor BIBA 01/2021
1	CC ChemokinesIBA 01/2021
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2020
1	Single-Chain AntibodiesIBA 12/2019
1	EpitopesIBA 12/2019
1	Factor XIII (Coagulation Factor XIII)IBA 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019
1	Pentosan Sulfuric Polyester (Pentosan Polysulfate)FDA Link 01/2019
1	Polycomb Repressive Complex 1IBA 01/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	Long Noncoding RNAIBA 12/2018
1	Familial apoceruloplasmin deficiencyIBA 07/2018
1	CopperIBA 07/2018

Therapy/Procedure

11	Therapeutics 11/2021 - 04/2002
6	Drug Therapy (Chemotherapy) 01/2022 - 11/2011
3	Hematopoietic Stem Cell Transplantation 08/2021 - 06/2008
2	Transplantation 11/2022 - 07/2021
2	Immunotherapy 07/2017 - 11/2016
2	Molecular Targeted Therapy 06/2014 - 11/2011
2	Highly Active Antiretroviral Therapy (HAART) 01/2008 - 04/2002
1	Cell Transplantation 03/2022
1	Stem Cell Transplantation 01/2021
1	Blood Transfusion (Blood Transfusions) 01/2019